MDWK / MDwerks, Inc. - تصريحات هيئة الأوراق المالية والبورصات، التقرير السنوي، بيان الوكيل

شركة MDwerks، المحدودة
US ˙ OTCPK

الإحصائيات الأساسية
CIK 1295514
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to MDwerks, Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
August 13, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from to MDwerks, Inc. (Exact name of registrant as specified in its charter)

July 30, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 MDWerks, Inc. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Number

July 30, 2025 EX-99.1

MDWerks to Deliver Molecular Sawdust Drying System to Leading U.S. Lumber Company Leverages proprietary molecular energy wave technology to consistently, efficiently and cost-effectively dry sawdust for wood pellet production

Exhibit 99.1 MDWerks to Deliver Molecular Sawdust Drying System to Leading U.S. Lumber Company Leverages proprietary molecular energy wave technology to consistently, efficiently and cost-effectively dry sawdust for wood pellet production Green Cove Springs, FL – July 30, 2025 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of

July 22, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2025 MDWerks, Inc. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2025 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Number

July 22, 2025 EX-99.1

MDWerks’ Two Trees Beverage Subsidiary to Install New Spirits Rapid Aging System Expected to approximately quintuple Two Trees’ spirits production capacity

Exhibit 99.1 MDWerks’ Two Trees Beverage Subsidiary to Install New Spirits Rapid Aging System Expected to approximately quintuple Two Trees’ spirits production capacity Green Cove Springs, FL – July 22, 2025 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that its subsidiary, Two Trees

July 15, 2025 EX-FILING FEES

Filing Fees Exhibit

Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) MDwerks, Inc. (Exact Name of Registrant as Specified in its Charter) Fee Previously Paid Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stock, par value $0.0001 per share Other (2

July 15, 2025 S-8

As filed with the Securities and Exchange Commission on July 15, 2025

As filed with the Securities and Exchange Commission on July 15, 2025 Registration No.

July 15, 2025 EX-99.1

MDWerks, Inc. 2025 Equity Incentive Plan

Exhibit 99.1 MDWerks, Inc. 2025 Equity Incentive Plan Table of Contents Article I. Purposes and Definitions 1 Section 1.01 Purposes of this Plan; Structure. 1 Section 1.02 Definitions. 1 Section 1.03 Additional Interpretations. 6 Article II. Stock Subject to this Plan; Administration. 6 Section 2.01 Stock Subject to this Plan. 6 Section 2.02 Administration of this Plan. 7 Section 2.03 Eligibility.

July 9, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2025 MDWerks, Inc. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2025 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Number)

July 9, 2025 EX-99.1

MDWerks’ Two Trees Beverage Subsidiary Receives Three 2025 SIP Awards

Exhibit 99.1 MDWerks’ Two Trees Beverage Subsidiary Receives Three 2025 SIP Awards Green Cove Springs, FL – July 9, 2025 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that its subsidiary, Two Trees Beverage Company (“Two Trees”), received three 2025 SIP Awards, including a Silver Med

May 29, 2025 EX-99.1

MDWerks Appoints New Transfer Agent

Exhibit 99.1 MDWerks Appoints New Transfer Agent Green Cove Springs, FL – May 29, 2025 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that the Company has appointed Continental Stock Transfer & Trust Company as its new transfer agent, effective June 2, 2025. Shareholders do not need t

May 29, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2025 MDWerks, Inc. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2025 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Number)

May 13, 2025 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2025 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Number)

May 13, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from to MDwerks, Inc. (Exact name of registrant as specified in its charter)

May 13, 2025 EX-99.1

MDWerks Issues Shareholder Update

Exhibit 99.1 MDWerks Issues Shareholder Update Green Cove Springs, FL – May 13, 2025 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today issued the following shareholder update from its Chief Executive Officer, Steven Laker. Dear Fellow Shareholders, With our first quarter results of 2025 now behind

March 25, 2025 EX-19.1

Insider trading policy of the registrant.*

Exhibit 19.1 POLICY ON INSIDER TRADING MDwerks, INC. Company “insiders” are subject to individual responsibilities and restrictions in addition to the responsibilities and obligations of the company itself. An “Insider” of a company is a person who is a director, officer, contractor, employee, advisor or consultant in possession of nonpublic material information regarding a company, as well as a s

March 25, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission File No. 000-56299 MDwerks, Inc. (Exact name of

March 25, 2025 EX-4.1

Description of securities.*

Exhibit 4.1 DESCRIPTION OF CAPITAL STOCK The following description of our capital stock is based upon our certificate of incorporation, our bylaws and applicable provisions of law, in each case as currently in effect. This discussion does not purport to be complete and is qualified in its entirety by reference to our certificate of incorporation, as amended, and our bylaws, as amended, copies of w

March 10, 2025 EX-10.1

Executive Employment Agreement dated March 1, 2025, between David Stephens and the registrant.

Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), entered into effective March 1, 2025, by and between MDWERKS, Inc. (Symbol: MDWK), a Florida corporation with an address of 411 Walnut Street, Suite 20125, Green Cove Springs, Florida 32043 (the “Company”) with David Stephens, an individual resident of the State of Texas with an address in The Woodl

March 10, 2025 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2025 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Numbe

March 10, 2025 EX-99.1

MDWerks Appoints David Stephens as Chief Financial Officer

Exhibit 99.1 MDWerks Appoints David Stephens as Chief Financial Officer Green Cove Springs, FL – March 10, 2025 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced the appointment of David Stephens as the Company’s Chief Financial Officer, effective March 1, 2025. Mr. Stephens brings to MD

February 19, 2025 EX-99.1

MDWerks Announces Two New Contracts to Deploy its Proprietary Spirits Rapid Aging System at Industry-Leading Spirits Companies

Exhibit 99.1 MDWerks Announces Two New Contracts to Deploy its Proprietary Spirits Rapid Aging System at Industry-Leading Spirits Companies Green Cove Springs, FL – February 19, 2025 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that its subsidiary, Two Trees Beverage Company (“Two T

February 19, 2025 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2025 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Nu

February 18, 2025 EX-99.1

MDWerks Provides Information Regarding Removal of Share Restriction

Exhibit 99.1 MDWerks Provides Information Regarding Removal of Share Restriction Green Cove Springs, FL – February 14, 2025 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that shareholders of MDWerks who hold restricted securities of the Company and have held them for at least six (6)

February 18, 2025 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2025 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Nu

January 29, 2025 8-K

Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2025 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Num

December 17, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2024 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Nu

December 17, 2024 EX-99.1

MDWerks’ RF Specialties Subsidiary Awarded New Contract to Maintain Mann-Russell Tube Based Radio Frequency Equipment across USNR’s Global Installed Base

Exhibit 99.1 MDWerks’ RF Specialties Subsidiary Awarded New Contract to Maintain Mann-Russell Tube Based Radio Frequency Equipment across USNR’s Global Installed Base Green Cove Springs, FL – December 17, 2024 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that the Company’s RF Specia

December 6, 2024 EX-99.1

MDWerks Expands its Board with the Appointment of Richard Blackstone as a New Independent Director

Exhibit 99.1 MDWerks Expands its Board with the Appointment of Richard Blackstone as a New Independent Director Green Cove Springs, FL – December 6, 2024 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced the expansion of the Company’s Board of Directors (the “Board”) to five members with

December 6, 2024 EX-10.1

Independent Director Agreement between Richard Blackstone and the registrant, dated December 3, 2024.

Exhibit 10.1 MDWerks, Inc. Independent Director Agreement (Director Name: [XXX]) Dated as of [], 2024 This Independent Director Agreement (this “Agreement”), dated and made effective as of the date first set forth above (the “Effective Date”), is entered into by and between MDWerks, Inc., a Delaware Corporation (“Company”), and [XXX] (“Director”). The Company and Director may be referred to herein

December 6, 2024 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2024 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Num

December 4, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2024 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Num

December 4, 2024 EX-99.1

MDWerks’ Key Intellectual Property Assets Valued at Approximately $400 Million by Leading Independent Financial Advisory Firm

Exhibit 99.1 MDWerks’ Key Intellectual Property Assets Valued at Approximately $400 Million by Leading Independent Financial Advisory Firm Green Cove Springs, FL – December 4, 2024 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that a nationally recognized tax, valuation, and financia

November 21, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2024 MDWerks, Inc. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2024 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Nu

November 21, 2024 EX-99.1

MDWerks Announces Uplisting to OTCQB Venture Market

Exhibit 99.1 MDWerks Announces Uplisting to OTCQB Venture Market Green Cove Springs, FL – November 21, 2024 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTC: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that the Company’s stock has been approved by OTC Markets Group Inc. for uplisting from the OTC Pink Open Market to the OTCQB Ventur

November 19, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2024 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Nu

November 19, 2024 EX-10.1

Independent Director Agreement dated November 18, 2024, between Timothy Brocopp and the registrant.

Exhibit 10.1 MDWerks, Inc. Independent Director Agreement (Director Name: [XXX]) Dated as of [], 2024 This Independent Director Agreement (this “Agreement”), dated and made effective as of the date first set forth above (the “Effective Date”), is entered into by and between MDWerks, Inc., a Delaware Corporation (“Company”), and [XXX] (“Director”). The Company and Director may be referred to herein

November 14, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from to MDwerks, Inc. (Exact name of registrant as specified in its char

November 12, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Material Modification to Rights of Security Holders, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2024 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Num

November 12, 2024 EX-10.2

Executive Employment Agreement dated November 7, 2024, between James Cassidy and the registrant

Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), entered into retroactive to January 1, 2024, by and between MDWERKS, Inc. (Symbol: MDWK), a Florida corporation with an address of 411 Walnut Street, Suite 20125, Green Cove Springs, Florida 32043 (the “Company”) with James Cassidy, an individual resident of the State of North Carolina (“Executive”)

November 12, 2024 EX-10.1

Executive Employment Agreement dated November 7, 2024, between Steven Laker and the registrant.

Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), entered into retroactive to July 15, 2024, by and between MDWERKS, Inc. (Symbol: MDWK), a Florida corporation with an address of 411 Walnut Street, Suite 20125, Green Cove Springs, Florida 32043 (the “Company”) with Steven Laker, an individual resident of the State of New York (“Executive”)(“Company

October 15, 2024 EX-19.1

Insider trading policy of the registrant.*

Exhibit 19.1 POLICY ON INSIDER TRADING MDwerks, INC. Company “insiders” are subject to individual responsibilities and restrictions in addition to the responsibilities and obligations of the company itself. An “Insider” of a company is a person who is a director, officer, contractor, employee, advisor or consultant in possession of nonpublic material information regarding a company, as well as a s

October 15, 2024 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission File No. 000-56299 MDwerks,

October 15, 2024 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0

August 14, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from to MDwerks, Inc. (Exact name of registrant as specified in its charter)

July 9, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT For the transition period from to MDwerks, Inc. (Exact name of small business issuer as specified in its chart

June 28, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission File No. 000-56299 MDwerks, Inc. (Exact name of

June 28, 2024 EX-4.1

Description of securities.*

Exhibit 4.1 DESCRIPTION OF CAPITAL STOCK The following description of our capital stock is based upon our certificate of incorporation, our bylaws and applicable provisions of law, in each case as currently in effect. This discussion does not purport to be complete and is qualified in its entirety by reference to our certificate of incorporation, as amended, and our bylaws, as amended, copies of w

June 28, 2024 EX-19.1

Insider trading policy of the registrant.*

Exhibit 19.1 POLICY ON INSIDER TRADING MDwerks, INC. Company “insiders” are subject to individual responsibilities and restrictions in addition to the responsibilities and obligations of the company itself. An “Insider” of a company is a person who is a director, officer, contractor, employee, advisor or consultant in possession of nonpublic material information regarding a company, as well as a s

May 24, 2024 EX-99.1

MDWerks Common Stock Transitions to OTC Expert Market

Exhibit 99.1 MDWerks Common Stock Transitions to OTC Expert Market May 22, 2024 Green Cove Springs, FL – May 24, 2024 – MDWerks, Inc. (“MDWerks” or the “Company”), a forward-thinking company leading the charge in the world of sustainable technology, today announced that its common stock has transitioned to trading on the OTC Expert Market, where it can be found under the ticker symbol “MDWK,” beca

May 24, 2024 EX-99.4

UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS

Exhibit 99.4 UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS The following unaudited pro forma combined financial data are presented to illustrate the effect of the following acquisitions (“the Acquisitions”): 1. On February 13, 2023, MDwerks, Inc. (the “Company”) entered into a Merger Agreement (the “Merger Agreement”), by and between the Company, MD-TT Merger Sub, Inc., a wholly owned subsidia

May 24, 2024 EX-99.2

RF Specialties, LLC Audited Financial Statements December 31, 2022 and 2021 Table of Contents

Exhibit 99.2 RF Specialties, LLC Audited Financial Statements December 31, 2022 and 2021 Table of Contents Report of Independent Registered Public Accounting Firm 1 Balance Sheets 2 Statements of Operations 3 Statements of Changes in Members’ Equity (Deficit) 4 Statements of Cash Flows 5 Notes to the Financial Statements 6 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Dir

May 24, 2024 EX-99.3

RF Specialties, LLC Unaudited Financial Statements September 30, 2023 Table of Contents

Exhibit 99.3 RF Specialties, LLC Unaudited Financial Statements September 30, 2023 Table of Contents Unaudited Balance Sheets 1 Unaudited Statements of Operations 2 Unaudited Statements of Changes in Members’ Equity (Deficit) 3 Unaudited Statement of Cash Flows 4 Notes to the Unaudited Financial Statements 5 RF Specialties, LLC Balance Sheets (Unaudited) September 30, 2023 December 31, 2022 ASSETS

May 24, 2024 8-K

Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2023 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation or organization) (Co

May 24, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2024 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Number)

May 20, 2024 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-56299 NOTIFICATION OF LATE FILING CUSIP NUMBER 582829107 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transi

April 1, 2024 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 MDWerks, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 MDWerks, Inc. FORM 12b-25 SEC FILE NUMBER 000-56299 NOTIFICATION OF LATE FILING CUSIP NUMBER 582829107 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on F

February 6, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2024 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Num

February 6, 2024 EX-99.1

MDWerks’ Two Trees Beverages Subsidiary Expands and Extends Collaboration with Tim Smith of Discovery Channel’s Moonshiners in New 15-Year Agreement

Exhibit 99.1 MDWerks’ Two Trees Beverages Subsidiary Expands and Extends Collaboration with Tim Smith of Discovery Channel’s Moonshiners in New 15-Year Agreement Green Cove Springs, FL – February 6, 2024 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTC: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that the Company’s award-winning Two

January 23, 2024 EX-99.1

MDWerks’ Two Trees Beverages Subsidiary Announces Co-Sponsorship of Team Combat League in New Multi-Year Agreement

Exhibit 99.1 MDWerks’ Two Trees Beverages Subsidiary Announces Co-Sponsorship of Team Combat League in New Multi-Year Agreement Green Cove Springs, FL – January 23, 2024 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTC: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that the Company’s award-winning Two Trees Beverages subsidiary (“Two

January 23, 2024 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2024 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Num

December 28, 2023 EX-99.1

MDWerks Acquires RF Specialties, LLC Platform Technology Behind Sustainably Matured™ Accelerated Liquid Maturation Process Provides MDWerks with Multi-Industry Expansion Opportunities

Exhibit 99.1 MDWerks Acquires RF Specialties, LLC Platform Technology Behind Sustainably Matured™ Accelerated Liquid Maturation Process Provides MDWerks with Multi-Industry Expansion Opportunities Green Cove Springs, FL – December 28, 2023 – MDWerks, Inc. (“MDWerks” or the “Company”) (OTC: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced

December 28, 2023 EX-17.1

Resignation Letter from Michael Nordlicht dated December 27, 2023.

Exhibit 17.1 December 27, 2023 MDwerks Inc. 411 Walnut Street, Suite 10125 Green Cove Springs, FL Ladies and Gentlemen: This letter confirms that I hereby resign from the Board of Directors of MDwerks Inc. (the “Company”) and from all offices that I hold effective immediately. My resignation is not the result of any disagreement with the Company on any matter relating to its operation, policies (i

December 28, 2023 8-K

Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2023 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Nu

December 27, 2023 8-K/A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Change in Shell Company Status, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 8, 2023 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation o

December 27, 2023 EX-10.1

Amendment No. 1 dated as of December 20, 2023 to the Exchange Agreement entered into between MDwerks, Inc. and Keith Mort dated January 19, 2023 (Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 27, 2023).

Exhibit 10.1

December 27, 2023 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2023 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Nu

December 12, 2023 EX-10.6

First Amendment to Consulting Agreement between Two Trees Beverage Company and Joe Ragazzo dated September 19, 2022

Exhibit 10.6 FIRST AMENDMENT TO CONSULTING AGREEMENT THIS First AMENDMENT TO CONSULTING AGREEMENT (the “First Amendment”) is made as of September 19, 2022 by and between Two Trees Beverage Company (the “Client”) and Joe Ragazzo (the “Consultant”), each of whom may be referred to herein as a “Party” and together as “Parties”. BACKGROUND WHEREAS, On , 2022, the Parties executed that certain consulti

December 12, 2023 EX-99.4

MDWerks Acquires Two Trees Beverage Company Disruptive, Proprietary and Proven Sustainably Matured ™ Liquid Maturation Technology Produces New Spirits in Days, Not Years, While Eliminating the Costs, Waste, and Environmental Impact of Wood Barrels Tr

Exhibit 99.4 MDWerks Acquires Two Trees Beverage Company Disruptive, Proprietary and Proven Sustainably Matured ™ Liquid Maturation Technology Produces New Spirits in Days, Not Years, While Eliminating the Costs, Waste, and Environmental Impact of Wood Barrels Transaction Brings Award-Winning American Whiskey Portfolio of Two Trees® and Tim Smith Spirits® Brands Green Cove Springs, FL – December 1

December 12, 2023 EX-99.2

Two Trees Beverage Company Consolidated Unaudited Financial Statements September 30, 2023 Table of Contents

Exhibit 99.2 Two Trees Beverage Company Consolidated Unaudited Financial Statements September 30, 2023 Table of Contents Consolidated Balance Sheets 1 Consolidated Statements of Operations 2 Consolidated Statements of Changes in Stockholders’ Equity (Deficit) 3 Consolidated Statement of Cash Flows 4 Notes to the Consolidated Financial Statements 5 Two Trees Beverage Company Consolidated Balance Sh

December 12, 2023 EX-10.2

Form of MDwerks Option between MDwerks, Inc. and a Holder

Exhibit 10.2 MDwerks, Inc. - Option Award Agreement Holder: [] Dated as of [], 2023 This Option Award Agreement (this “Agreement”) dated as of the date first set forth above (the “Award Date”) is entered into by and between MDwerks, Inc., a Delaware corporation (the “Company”), and the holder as named above (the “Holder”). The Company and Holder may collective be referred to as the “Parties” and e

December 12, 2023 EX-21.1

Subsidiaries of the Registrant.

Exhibit 21.1 List of Subsidiaries of MDwerks, Inc. Entity Name Place of Organization Two Trees Beverage Company* Delaware Radio Aged Spirits, LLC** North Carolina Radio Aged Beer, LLC** North Carolina RF Kettle Company, LLC ** North Carolina Two Trees Distilling Company, LLC** North Carolina Prost Beverage Company** Florida * 100% owned subsidiary of MDwerks, Inc. ** 100% owned subsidiary of Two T

December 12, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Change in Shell Company Status, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2023 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation or organization) (Com

December 12, 2023 EX-2.4

Amendment and Waiver Pursuant to Merger Agreement dated December 7, 2023 by and among MDwerks, Inc., MD-TT Merger Sub, Inc. and Two Trees Beverage Company.

Exhibit 2.4 Amendment and Waiver Pursuant to Merger Agreement December 7, 2023 This Amendment and Waiver Pursuant to Merger Agreement (this “Amendment and Waiver”) is made and entered into as of the date first set forth above (the “Amendment Date”) by and among (i) MDwerks, Inc., a Delaware corporation (the “Company”); (ii) MD-TT Merger Sub, Inc., a Delaware corporation and a wholly owned subsidia

December 12, 2023 EX-99.3

UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS

Exhibit 99.3 UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS The following unaudited pro forma combined financial data are presented to illustrate the effect of the following merger agreement (the “Merger”): On February 13, 2023, MDwerks, Inc. (the “Company”) entered into a Merger Agreement (the “Merger Agreement”), by and between the Company, MD-TT Merger Sub, Inc., a wholly owned subsidiary of

December 12, 2023 EX-10.3

Form of Indemnification Agreement between MDwerks, Inc. and James P. Cassidy.

Exhibit 10.3 Form of Indemnification Agreement Dated as of [], 2023 This Indemnification Agreement (this “Agreement”) is entered into as of the date first set forth above (the “Effective Date”) by and between (i) MDwerks, Inc., a Delaware corporation (the “Company”); and (ii) [] (“Indemnitor”). Each of Indemnitor and the Company may be referred to herein collectively as the “Parties” and separatel

December 12, 2023 EX-99.1

Two Trees Beverage Company Audited Consolidated Financial Statements December 31, 2022 and 2021 Table of Contents

Exhibit 99.1 Two Trees Beverage Company Audited Consolidated Financial Statements December 31, 2022 and 2021 Table of Contents Report of Independent Registered Public Accounting Firm 1 Consolidated Balance Sheets 2 Consolidated Statements of Operations 3 Consolidated Statements of Changes in Stockholders’ Equity (Deficit) 4 Consolidated Statement of Cash Flows 5 Notes to the Consolidated Financial

December 12, 2023 EX-10.1

Form of Option Rollover Agreement between MDwerks, Inc. and a Rollover Holder.

Exhibit 10.1 Option Rollover Agreement Rollover Holder: [] This Option Rollover Agreement (this “Agreement”) is entered into as of [], 2023 (the “Effective Date”), by and between the MDwerks, Inc., a Delaware corporation (the “Company”), and the person or entity as set forth above (the “Rollover Holder”). The Company and the Rollover Holder may each be referred to herein individually as a “Party”

December 12, 2023 EX-10.5

Consulting Agreement between Two Trees Beverage Company and Joe Ragazzo dated July 18, 2022.

Exhibit 10.5 Consulting Agreement This consulting agreement (The “Agreement”) is dated this 18th day of July, 2022. Client Two Trees Beverage Company 17 Continuum Dr, Fletcher, NC 28732 (the “client”) Consultant Joe Ragazzo 100 District Drive, Apt 302 Asheville, NC 28803 (the “Consultant”) Background a. The Client is of the opinion that the Consultant has the necessary qualifications, experience a

November 14, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT For the transition period from to MDwerks, Inc. (Exact name of small business issuer as specified in its c

September 13, 2023 EX-2.1

Amendment No. 2 to Merger Agreement dated September 11, 2023 by and among MDwerks, Inc., MD-TT Merger Sub, Inc. and Two Trees Beverage Company (Incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 11, 2023).

Exhibit 2.1 Amendment No. 2 To Merger Agreement This Amendment No. 2 to Merger Agreement (this “Amendment”) is made and entered into as of September 11, 2023 (the “Amendment Date”) by and among (i) MDwerks, Inc., a Delaware corporation (the “Company”); (ii) MD-TT Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”); and (iii) Two Trees Beverage Co.,

September 13, 2023 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2023 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File N

August 31, 2023 8-K

Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2023 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Numb

August 31, 2023 EX-2.1

Asset Purchase Agreement between MDwerks, Inc. and Dream Workz Automotive LLC dated as of August 25, 2023, 2023 (Incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 25, 2023).

Exhibit 2.1 Asset Purchase Agreement by and among MDwerks, Inc. and Dream Workz Automotive LLC TABLE OF CONTENTS PAGE Article I. Definitions and Interpretation 1 Section 1.01 Definitions. 1 Section 1.02 Interpretive Provisions. 2 Article II. Purchase and Sale 3 Section 2.01 The Purchase and Sale. 3 Section 2.02 Closing 3 Section 2.03 Conveyance Taxes. 3 Article III. Representations and Warranties

August 4, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT For the transition period from to MDwerks, Inc. (Exact name of small business issuer as specified in its charte

June 8, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT For the transition period from to MDwerks, Inc. (Exact name of small business issuer as specified in its chart

June 6, 2023 EX-2.1

Asset Purchase Agreement, dated as of May 31, 2023, by and between the registrant and Automotive Transmission Engineering Corp.

Exhibit 2.1 Asset Purchase Agreement BY AND AMONG MDwerks, Inc. AND Automotive Transmission Engineering Corp. TABLE OF CONTENTS PAGE ARTICLE I. Definitions and Interpretation 1 Section 1.01 Definitions 1 Section 1.02 Interpretive Provisions 2 ARTICLE II. Purchase and Sale 3 Section 2.01 The Purchase and Sale 3 Section 2.02 Closing 3 Section 2.03 Conveyance Taxes 3 ARTICLE III. Representations and

June 6, 2023 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2023 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Number)

May 31, 2023 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A ☒  ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2022 or ☐  TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission File No. 000-56299 MDwerks, Inc. (Exact nam

May 19, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2023 MDwerks, Inc. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2023 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Number)

May 16, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-56299 CUSIP NUMBER NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: March 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Repor

March 27, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒  ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2022 or ☐  TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission File No. 000-56299 MDwerks, Inc. (Exact name

February 17, 2023 EX-2.2

Amendment No. 1 to Merger Agreement, dated February 16, 2023, by and among MDwerks, Inc., MD-TT Merger Sub, Inc. and Two Trees Beverage Co. (incorporated by reference to Exhibit 2.2 to the registrant’s Current Report on Form 8-K filed with the SEC on February 17, 2023).

EX-2.2 3 ex2-2.htm Exhibit 2.2 Amendment No. 1 To Merger Agreement This Amendment No. 1 to Merger Agreement (this “Amendment”) is made and entered into as of February 16, 2023 (the “Amendment Date”) by and among (i) MDwerks, Inc., a Delaware corporation (the “Company”); (ii) MD-TT Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”); and (iii) Two Tr

February 17, 2023 EX-2.1

Merger Agreement, dated February 13, 2023, by and among MDwerks, Inc., MD-TT Merger Sub, Inc. and Two Trees Beverage Co. (incorporated by reference to Exhibit 2.1 to the registrant’s Current Report on Form 8-K filed with the SEC on February 17, 2023).

Exhibit 2.1 Merger Agreement by and among MDwerks, Inc., MD-TT Merger Sub, Inc. And Two Trees Beverage Co. TABLE OF CONTENTS PAGE ARTICLE I. Definitions and Interpretations 1 Section 1.01 Definitions. 1 Section 1.02 Interpretive Provisions. 6 ARTICLE II. The Transactions 7 Section 2.01 The Merger and Effects of the Merger. 7 Section 2.02 The Closing. 7 Section 2.03 Effective Time. 7 Section 2.04 T

February 17, 2023 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2023 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Nu

February 3, 2023 EX-16.1

Letter of TAAD LLP dated February 2, 2023 (Incorporated by reference to Exhibit 16.1 of the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 2, 2023).

Exhibit 16.1 February 2, 2023 Office of the Chief Accountant U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: MDwerks, Inc. Commission File Number 000-56299 Dear Sirs/Madams: We have read Item 4.01 of MDwerks, Inc.’s (the “Company”) Form 8-K to be filed on February 2, 2023 and are in agreement with the statements relating only to TAAD, LLP. contained therein. We

February 3, 2023 8-K

Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2023 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation) (Commission File Num

January 25, 2023 EX-10.1

Exchange Agreement, dated as of January 19, 2023, by and among the registrant, RF Specialties LLC and Keith A. Mort (incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed with the SEC on January 25, 2023).

Exhibit 10.1 Exchange Agreement by and among MDwerks, Inc., RF Specialties LLC AND Keith A. Mort as the Sole Member of RF Specialties LLC TABLE OF CONTENTS PAGE Article I. Definitions and Interpretations 1 Section 1.01 Definitions. 1 Section 1.02 Interpretive Provisions. 6 Article II. The Transactions 6 Section 2.01 The Exchange. 6 Section 2.02 Closing 7 Section 2.03 RFS Deliverables at the Closin

January 25, 2023 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 19, 2023 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 000-56299 33-1095411 (State or other jurisdiction of incorporation or organization) (Com

January 23, 2023 8-K

Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2022 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 333-118155 33-1095411 (State or other jurisdiction of incorporation or organization) (C

December 9, 2022 8-K

Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2022 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 333-118155 33-1095411 (State or other jurisdiction of incorporation or organization) (Co

November 4, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT For the transition period from to MDwerks, Inc. (Exact name of small business issuer as specified in its c

September 19, 2022 EX-3.3

Certificate of Elimination of the registrant (Incorporated by reference to Exhibit 3.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on September 19, 2022).

Exhibit 3.3 CERTIFICATE OF ELIMINATION OF CERTIFICATE OF DESIGNATIONS OF PREFERENCES AND RIGHTS OF SERIES B CONVERTIBLE PREFERRED STOCK OF MDwerks, Inc. a Delaware corporation MDwerks, Inc., a Delaware corporation (the ?Corporation?), DOES HEREBY CERTIFY: That, pursuant to authority conferred on the Board of Directors of the Corporation by the Certificate of Incorporation of the Corporation (the ?

September 19, 2022 EX-3.1

Amended and Restated Certificate of Incorporation of the registrant (Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on September 19, 2022).

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MDwerks, Inc. MDwerks, Inc. (hereinafter referred to as the ?Corporation?), a corporation organized and existing under the laws of the State of Delaware, hereby certifies as follows: FIRST: The date of filing of the original Certificate of Incorporation of the Corporation with the Secretary of State of the State of Delaware is July 2

September 19, 2022 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2022 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 333-118155 33-1095411 (State or other jurisdiction of incorporation or organization) (

September 19, 2022 EX-3.2

Amended and Restated Bylaws of the registrant (Incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on September 19, 2022).

EX-3.2 3 ex3-2.htm Exhibit 3.2 Amended and Restated Bylaws Of MDwerks, Inc. a Delaware corporation Adopted September 13, 2022 1. Offices. MDwerks, Inc. (the “Corporation”) may have an office or offices, and keep the books and records of the Corporation, except as may otherwise be required by applicable law, at such other place or places, either within or without the State of Delaware, as the Board

August 22, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT For the transition period from to MDwerks, Inc. (Exact name of small business issuer as specified in its charte

August 16, 2022 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period

July 27, 2022 EX-10.1

Stock Purchase Agreement, dated July 21, 2022, by and between the Company, Tradition Reserve I LLC and MDWerks, Inc.

Exhibit 10.1 Stock Purchase Agreement BY AND AMONG Tradition Reserve I LLC, MDwerks, Inc. And Ronin Equity Partners, Inc. Table of Contents Article I. Definitions and Interpretation 1 Section 1.01 Defined Terms. 1 Section 1.02 Interpretation. 7 Article II. The Transactions 7 Section 2.01 The Purchase. 7 Section 2.02 Forgiveness of Debt. 8 Section 2.03 Actions at the Closing. 8 Section 2.04 Closing

July 27, 2022 8-K

Entry into a Material Definitive Agreement, Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2022 MDWerks, Inc. (Exact name of registrant as specified in its charter) Delaware 333-118155 33-1095411 (State or other jurisdiction of incorporation or organization) (Commi

May 23, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT For the transition period from to MDwerks, Inc. (Exact name of small business issuer as spec

May 13, 2022 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

NT 10-Q 1 mdwerksext.htm EXTENSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [] Form 10-K [] Form 20-F [] Form 11-K [X] Form 10-Q [] Form 10-D [] Form N-CEN [] Form N-CSR For Period Ended: March 31, 2022 [] Transition Report on Form 10-K [] Transition Report on Form 20-F [] Transition Report on Form 11-K [] Transiti

April 15, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒  ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2021 or ☐  TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission File No. 333-118155 MDwerks

March 31, 2022 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [X] Form 10-K [] Form 20-F [] Form 11-K [] Form 10-Q [] Form 10-D [] Form N-CEN [] Form N-CSR For Period Ended: December 31, 2021 [] Transition Report on Form 10-K [] Transition Report on Form 20-F [] Transition Report on Form 11-K [] Transition Report on Form 10-Q For the T

November 15, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT For the transition period from to MDwerks, Inc. (Exact name of small business issuer as

August 23, 2021 CORRESP

MDwerks, Inc. 12 Park Mirage Lane Rancho Mirage, CA 92270

MDwerks, Inc. 12 Park Mirage Lane Rancho Mirage, CA 92270 Date: August 23, 2021 James Lopez Division of Corporation Finance Office of Real Estate & Construction Securities and Exchange Commission (202) 551-3536 Re: MD Werks Inc. Amendment to Registration Statement on Form 10 Filed August 6, 2021 File No. 000-56299 In response to our telephone conversation on August 20, 2021, we hereby confirm that

August 6, 2021 10-12G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10/A Amendment No. 1 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 MDwerks, Inc. (Exact name of registr

10-12G/A 1 mdwerks1012ga.htm AMENDMENT TO FORM 10-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10/A Amendment No. 1 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 33-1095411 (State or other jurisdiction of incorporati

June 23, 2021 10-12G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 MDwerks, Inc. (Exact name of registrant as specified i

10-12G 1 mdwerks1012g.htm FORM10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 MDwerks, Inc. (Exact name of registrant as specified in its charter) Delaware 33-1095411 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Id

February 17, 2010 15-15D

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 333-118155 MDWERKS, INC. (Exact name of registrant as specified in its chart

February 12, 2010 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 8, 2010 MDWERKS, INC.

November 23, 2009 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2009 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File Number: 333-118155 MDWERKS, INC. (Exact name o

November 16, 2009 NT 10-Q

SEC FILE NUMBER

SEC FILE NUMBER 333-118155 IRS ID NUMBER 33-1095411 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

October 8, 2009 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 28, 2009 MDWERKS, INC.

August 14, 2009 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2009 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File Number: 333-118155 MDWERKS, INC. (Exact name of reg

June 3, 2009 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 3, 2009 MDWERKS, INC.

June 3, 2009 10-Q/A

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2009 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File Number: 333-118155 MDWERKS, INC. (Exact name of

June 3, 2009 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K/A (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE OF 1934 For the fiscal year ended December 31, 2008 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE OF 1934 For the transition period from to Commission file number 333-118155 MDWERKS, INC.

May 15, 2009 8-K

Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 14, 2009 MDWERKS, INC.

May 15, 2009 EX-10.2

EMPLOYMENT AGREEMENT (Executive Level)

Exhibit 10.2 EMPLOYMENT AGREEMENT (Executive Level) AGREEMENT, dated as of May 15, 2009, between MDwerks, Inc., a Delaware corporation (the "Company"), and the Executive identified on Exhibit A attached hereto (the "Executive"). W I T N E S S E T H: WHEREAS, the Company desires to retain the services of the Executive and to that end desires to enter into a contract of employment with him, upon the

May 15, 2009 EX-10.1

MDWERKS, INC. RESTRICTED STOCK AGREEMENT

EX-10.1 2 v149937ex10-1.htm Exhibit 10.1 MDWERKS, INC. RESTRICTED STOCK AGREEMENT FOR Agreement 1. Award of Restricted Stock. The Committee hereby grants, as of , 2009 (the “Date of Grant”), to , restricted shares of the Company’s Common Stock, par value $.001 per share (collectively, the “Restricted Stock”). The Restricted Stock shall be subject to the terms, provisions and restrictions set forth

May 14, 2009 10-Q

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2009 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File Number: 333-118155 MDWERKS, INC. (Exact name of re

April 22, 2009 EX-10.1

GUARANTY AGREEMENT

EX-10.1 7 v146900ex10-1.htm Exhibit 10.1 GUARANTY AGREEMENT THIS GUARANTY AGREEMENT (this “Guaranty”) is made as of April 15, 2009, by and between XENI MEDICAL BILLING, CORP., a Delaware corporation (“Guarantor”), and VICIS CAPITAL MASTER FUND, a sub-trust of Vicis Capital Series Master Trust, a unit trust organized and existing under the laws of the Cayman Islands (the “Lender”). RECITALS A. Guar

April 22, 2009 EX-4.3

MDWERKS, INC. SERIES K WARRANT TO PURCHASE COMMON STOCK

EX-4.3 4 v146900ex4-3.htm Exhibit 4.3 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATIO

April 22, 2009 EX-10.11

April 15, 2009

EX-10.11 17 v146900ex10-11.htm Exhibit 10.11 April 15, 2009 MDwerks, Inc. Attention: David Barnes Windolph Center, Suite I 1020 N.W. 6th Street Deerfield Beach, FL 33442 Re: Deferral of Principal and Interest Payments Dear David: Reference is made to the indebtedness evidenced by: (a) that certain First Amended and Restated Senior Secured Convertible Note dated September 28, 2007, as amended by Am

April 22, 2009 EX-10.10

GUARANTOR SECURITY AGREEMENT

EX-10.10 16 v146900ex10-10.htm Exhibit 10.10 GUARANTOR SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Security Agreement”) is made as of April 15, 2009, by and between XENI PATIENT ACCESS SOLUTIONS, INC., a Florida corporation (“Debtor”), and VICIS CAPITAL MASTER FUND, a sub-trust of Vicis Capital Series Master Trust, a unit trust organized and existing under the laws of the Cayman Islands (the

April 22, 2009 EX-10.9

GUARANTOR SECURITY AGREEMENT

EX-10.9 15 v146900ex10-9.htm Exhibit 10.9 GUARANTOR SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Security Agreement”) is made as of April 15, 2009, by and between XENI MEDICAL BILLING, CORP., a Delaware corporation (“Debtor”), and VICIS CAPITAL MASTER FUND, a sub-trust of Vicis Capital Series Master Trust, a unit trust organized and existing under the laws of the Cayman Islands (the “Lender”)

April 22, 2009 EX-10.6

SECURITY AGREEMENT

EX-10.6 12 v146900ex10-6.htm Exhibit 10.6 SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Security Agreement”) is made as of April 15, 2009, by and between XENI FINANCIAL SERVICES, CORP., a Florida corporation (“Debtor”), and VICIS CAPITAL MASTER FUND, a sub-trust of Vicis Capital Series Master Trust, a unit trust organized and existing under the laws of the Cayman Islands (the “Lender”). RECITA

April 22, 2009 EX-10.4

GUARANTY AGREEMENT

EX-10.4 10 v146900ex10-4.htm Exhibit 10.4 GUARANTY AGREEMENT THIS GUARANTY AGREEMENT (this “Guaranty”) is made as of April 15, 2009, by and between XENI PATIENT ACCESS SOLUTIONS, INC., a Florida corporation (“Guarantor”), and VICIS CAPITAL MASTER FUND, a sub-trust of Vicis Capital Series Master Trust, a unit trust organized and existing under the laws of the Cayman Islands (the “Lender”). RECITALS

April 22, 2009 EX-10.7

GUARANTOR SECURITY AGREEMENT

EX-10.7 13 v146900ex10-7.htm Exhibit 10.7 GUARANTOR SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Security Agreement”) is made as of April 15, 2009, by and between MDWERKS GLOBAL HOLDINGS, INC., a Florida corporation (“Debtor”), and VICIS CAPITAL MASTER FUND, a sub-trust of Vicis Capital Series Master Trust, a unit trust organized and existing under the laws of the Cayman Islands (the “Lender”

April 22, 2009 EX-4.1

LOAN AND SECURITIES PURCHASE AGREEMENT By and Between MDWERKS, INC., XENI FINANCIAL SERVICES, CORP. VICIS CAPITAL MASTER FUND DATED APRIL 15, 2009 LOAN AND SECURITIES PURCHASE AGREEMENT

EX-4.1 2 v146900ex4-1.htm Exhibit 4.1 LOAN AND SECURITIES PURCHASE AGREEMENT By and Between MDWERKS, INC., XENI FINANCIAL SERVICES, CORP. and VICIS CAPITAL MASTER FUND DATED APRIL 15, 2009 LOAN AND SECURITIES PURCHASE AGREEMENT This LOAN AND SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated this 15th day of April, 2009, is made by and between MDWERKS, INC., a Delaware corporation (“MDwerks” o

April 22, 2009 EX-4.4

MDWERKS, INC. TO SERIES J WARRANT CERTIFICATE NO. W-J-1 April 15, 2009

EX-4.4 5 v146900ex4-4.htm Exhibit 4.4 MDWERKS, INC. AMENDMENT TO SERIES J WARRANT CERTIFICATE NO. W-J-1 April 15, 2009 THIS AMENDMENT TO SERIES J WARRANT CERTIFICATE (the “AMENDMENT”) is by MDWERKS, INC., a Delaware corporation (the “COMPANY”), in favor of VICIS CAPITAL MASTER FUND, as holder (“HOLDER”) of that certain Series J Warrant to Purchase Common Stock, Certificate No. W-J-1 (the “WARRANT

April 22, 2009 EX-10.3

GUARANTY AGREEMENT

EX-10.3 9 v146900ex10-3.htm Exhibit 10.3 GUARANTY AGREEMENT THIS GUARANTY AGREEMENT (this “Guaranty”) is made as of April 15, 2009, by and between XENI MEDICAL SYSTEMS, INC., a Delaware corporation (“Guarantor”), and VICIS CAPITAL MASTER FUND, a sub-trust of Vicis Capital Series Master Trust, a unit trust organized and existing under the laws of the Cayman Islands (the “Lender”). RECITALS A. Guara

April 22, 2009 EX-4.2

SENIOR SECURED PROMISSORY NOTE

EX-4.2 3 v146900ex4-2.htm Exhibit 4.2 THIS SENIOR SECURED PROMISSORY NOTE HAS BEEN ACQUIRED FOR INVESTMENT PURPOSES ONLY AND NOT FOR DISTRIBUTION AND MAY BE TRANSFERRED OR OTHERWISE DISPOSED OF ONLY IN COMPLIANCE WITH THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND APPLICABLE STATE SECURITIES LAWS. THIS LEGEND SHALL BE ENDORSED UPON ANY PROMISSORY NOTE ISSUED IN EXCHANGE FOR THIS SECURED P

April 22, 2009 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 20, 2009 MDWERKS, INC.

April 22, 2009 EX-10.2

GUARANTY AGREEMENT

EX-10.2 8 v146900ex10-2.htm Exhibit 10.2 GUARANTY AGREEMENT THIS GUARANTY AGREEMENT (this “Guaranty”) is made as of April 15, 2009, by and between MDWERKS GLOBAL HOLDINGS, INC., a Florida corporation (“Guarantor”), and VICIS CAPITAL MASTER FUND, a sub-trust of Vicis Capital Series Master Trust, a unit trust organized and existing under the laws of the Cayman Islands (the “Lender”). RECITALS A. Gua

April 22, 2009 EX-4.5

REGISTRATION RIGHTS AGREEMENT

EX-4.5 6 v146900ex4-5.htm Exhibit 4.5 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement is made and entered into as of April 15, 2009 (as amended, modified or supplemented from time to time, this “Agreement”) by and between MDwerks, Inc., a Delaware corporation (the “Company”), and each securityholder identified on the signature pages hereto (each, including its successors and assig

April 22, 2009 EX-10.5

SECURITY AGREEMENT

EX-10.5 11 v146900ex10-5.htm Exhibit 10.5 SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Security Agreement”) is made as of April 15, 2009, by and between MDWERKS, INC., a Delaware corporation (“Debtor”), and VICIS CAPITAL MASTER FUND, a sub-trust of Vicis Capital Series Master Trust, a unit trust organized and existing under the laws of the Cayman Islands (the “Lender”). RECITALS A. Pursuant t

April 22, 2009 EX-99.1

MDWERKS SIGNS $3.2 MILLION LOAN AGREEMENT

Exhibit 99.1 FOR IMMEDIATE RELEASE MDWERKS SIGNS $3.2 MILLION LOAN AGREEMENT DEERFIELD BEACH, Fl. ? April 22, 2009 ? MDwerks, Inc. (OTCBB:MDWK) (?the Company?), announced today that it has received net proceeds of $3,108,550 pursuant to a loan agreement with Vicis Capital Master Fund (?Vicis?). The net funds reflect payment of a 2% original issue discount of $64,000 as well as professional and oth

April 22, 2009 EX-10.8

GUARANTOR SECURITY AGREEMENT

EX-10.8 14 v146900ex10-8.htm Exhibit 10.8 GUARANTOR SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Security Agreement”) is made as of April 15, 2009, by and between XENI MEDICAL SYSTEMS, INC., a Delaware corporation (“Debtor”), and VICIS CAPITAL MASTER FUND, a sub-trust of Vicis Capital Series Master Trust, a unit trust organized and existing under the laws of the Cayman Islands (the “Lender”).

April 15, 2009 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE OF 1934 For the fiscal year ended December 31, 2008 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE OF 1934 For the transition period from to Commission file number 333-118155 MDWERKS, INC.

April 2, 2009 CORRESP

MDwerks, Inc. 1020 NW 6th Street – Suite I, Deerfield Beach, FL 33442 Tel (954) 389-8300 Fax (954) 427-5871

Via Federal Express April 2, 2009 Stephen Krikorian Accounting Branch Chief United States Securities and Exchange Commission 100 F.

March 31, 2009 NT 10-K

SEC FILE NUMBER

SEC FILE NUMBER 333-118155 IRS ID NUMBER 33-1095411 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

February 27, 2009 CORRESP

MDwerks, Inc. 1020 NW 6th Street – Suite I, Deerfield Beach, FL 33442 Tel (954) 389-8300 Fax (954) 427-5871

Via Federal Express February 27, 2009 Stephen Krikorian Accounting Branch Chief United States Securities and Exchange Commission 100 F.

February 20, 2009 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 16, 2009 MDWERKS, INC.

February 20, 2009 CORRESP

MDwerks, Inc. 1020 NW 6th Street – Suite I, Deerfield Beach, FL 33442 Tel (954) 389-8300 Fax (954) 427-5871

February 20, 2009 Stephen Krikorian Accounting Branch Chief United States Securities and Exchange Commission 100 F.

February 20, 2009 EX-10.1

Consultant Agreement

Exhibit 10.1 Consultant Agreement Consultant Agreement, made as of February 16, 2009, between MDwerks, Inc. (the “Corporation”), Vandam Consulting Services, Inc, (the “Consultant”) and Howard B. Katz (“Katz”). Whereas, Katz intends to resign as Chairman, CEO and Director of the Corporation, and the Corporation wishes to assure itself of the services of Katz through the Consultant for the period pr

January 12, 2009 CORRESP

MDwerks, Inc. 1020 NW 6th Street – Suite I, Deerfield Beach, FL 33442 Tel (954) 389-8300 Fax (954) 427-5871

CORRESP 1 filename1.htm Via Federal Express January 12, 2009 Stephen Krikorian Accounting Branch Chief United States Securities and Exchange Commission 100 F. Street, N.E. Washington, D.C. 20549 Re: MDwerks, Inc. Form 10-KSB for the Fiscal Year Ended December 31, 2007 Filed March 27, 2008 Amended April 11, 2008 Form 10-Q for the Fiscal Quarter Ended September 30, 2008 File No. 333-118155 Dear Mr.

January 8, 2009 EX-4.2

AMENDED AND RESTATED SENIOR SECURED PROMISSORY NOTE

EX-4.2 3 v136532ex4-2.htm Exhibit 4.2 THIS AMENDED AND RESTATED SENIOR SECURED PROMISSORY NOTE HAS BEEN ACQUIRED FOR INVESTMENT PURPOSES ONLY AND NOT FOR DISTRIBUTION AND MAY BE TRANSFERRED OR OTHERWISE DISPOSED OF ONLY IN COMPLIANCE WITH THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND APPLICABLE STATE SECURITIES LAWS. THIS LEGEND SHALL BE ENDORSED UPON ANY PROMISSORY NOTE ISSUED IN EXCHAN

January 8, 2009 424B3

PROSPECTUS SUPPLEMENT NO. 12 PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 12 TO PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This prospectus supplement includes the attached two Current Reports on Form

January 8, 2009 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 31, 2008 MDWERKS, INC. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 31, 2008 MDWERKS, INC.

January 8, 2009 EX-4.1

FIRST AMENDMENT TO THE LOAN AND SECURITIES PURCHASE AGREEMENT

Exhibit 4.1 FIRST AMENDMENT TO THE LOAN AND SECURITIES PURCHASE AGREEMENT This FIRST AMENDMENT TO THE LOAN AND SECURITIES PURCHASE AGREEMENT (the “Amendment”), dated this 31st day of December, 2008, is made by and between MDWERKS, INC., a Delaware corporation (“MDwerks” or the “Company”), XENI FINANCIAL SERVICES, CORP., a Florida corporation (“XFSC” and along with MDwerks, each a “Borrower” and co

December 24, 2008 8-K

Material Modification to Rights of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 18, 2008 MDWERKS, INC.

December 24, 2008 EX-10.1

EMPLOYMENT AGREEMENT (Senior Executive Level)

EX-10.1 2 v135690ex10-1.htm EMPLOYMENT AGREEMENT (Senior Executive Level) AGREEMENT, dated as of December 1, 2008, between MDwerks, Inc., a Delaware corporation (the "Company"), and the Executive identified on Exhibit A attached hereto (the "Executive"). W I T N E S S E T H: WHEREAS, the Company desires to retain the services of the Executive and to that end desires to enter into a contract of emp

December 24, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 11 PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 11 TO PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This prospectus supplement includes the attached two Current Reports on Form

December 24, 2008 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 22, 2008 MDWERKS, INC. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 22, 2008 MDWERKS, INC.

December 22, 2008 CORRESP

MDwerks, Inc. 1020 NW 6th Street – Suite I, Deerfield Beach, FL 33442 Tel (954) 389-8300 Fax (954) 427-5871

December 22, 2008 Stephen Krikorian Accounting Branch Chief United States Securities and Exchange Commission 100 F.

December 5, 2008 CORRESP

MDwerks, Inc. 1020 NW 6th Street - Suite I, Deerfield Beach, FL 33442 Tel (954) 389-8300 Fax (954) 427-5871

Stephen Krikorian Accounting Branch Chief United States Securities and Exchange Commission 100 F.

November 20, 2008 EX-10.2

GUARANTY AGREEMENT

GUARANTY AGREEMENT THIS GUARANTY AGREEMENT (this “Guaranty”) is made as of November 14, 2008, by and between MDWERKS GLOBAL HOLDINGS, INC.

November 20, 2008 EX-10.3

GUARANTY AGREEMENT

EX-10.3 8 v133049ex10-3.htm GUARANTY AGREEMENT THIS GUARANTY AGREEMENT (this “Guaranty”) is made as of November 14, 2008, by and between XENI MEDICAL SYSTEMS, INC., a Delaware corporation (“Guarantor”), and DEBT OPPORTUNITY FUND, LLLP, a limited liability limited partnership organized under the laws of the State of Florida (the “Lender”). RECITALS A. Guarantor is either a direct or an indirect who

November 20, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 10 PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular ?Risk Factors? beginning on page 5 of the prospectus. This

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 10 TO PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular ?Risk Factors? beginning on page 5 of the prospectus. This prospectus supplement includes the attached Current Report on Form 8-K

November 20, 2008 EX-10.4

GUARANTY AGREEMENT

GUARANTY AGREEMENT THIS GUARANTY AGREEMENT (this “Guaranty”) is made as of November 14, 2008, by and between PATIENT PAYMENT SOLUTIONS, INC.

November 20, 2008 EX-4.2

SENIOR SECURED PROMISSORY NOTE

EX-4.2 3 v133049ex4-2.htm THIS SENIOR SECURED PROMISSORY NOTE HAS BEEN ACQUIRED FOR INVESTMENT PURPOSES ONLY AND NOT FOR DISTRIBUTION AND MAY BE TRANSFERRED OR OTHERWISE DISPOSED OF ONLY IN COMPLIANCE WITH THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND APPLICABLE STATE SECURITIES LAWS. THIS LEGEND SHALL BE ENDORSED UPON ANY PROMISSORY NOTE ISSUED IN EXCHANGE FOR THIS SECURED PROMISSORY NO

November 20, 2008 EX-4.3

MDWERKS, INC. SERIES J WARRANT TO PURCHASE COMMON STOCK

EX-4.3 4 v133049ex4-3.htm NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT

November 20, 2008 EX-10.9

GUARANTOR SECURITY AGREEMENT

GUARANTOR SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Security Agreement”) is made as of November 14, 2008, by and between XENI MEDICAL BILLING, CORP.

November 20, 2008 EX-99.1

MDWERKS SECURES FINANCING COMMITMENT FOR UP TO $10,014,000 TO FUND MEDICAL CLAIM PURCHASES FROM A PROSPECTIVE NEW CLIENT

FOR IMMEDIATE RELEASE MDWERKS SECURES FINANCING COMMITMENT FOR UP TO $10,014,000 TO FUND MEDICAL CLAIM PURCHASES FROM A PROSPECTIVE NEW CLIENT DEERFIELD BEACH, Fla.

November 20, 2008 EX-10.8

GUARANTOR SECURITY AGREEMENT

GUARANTOR SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Security Agreement”) is made as of November 14, 2008, by and between XENI MEDICAL SYSTEMS, INC.

November 20, 2008 EX-4.1

LOAN AND SECURITIES PURCHASE AGREEMENT By and Between MDWERKS, INC., XENI FINANCIAL SERVICES, CORP. DEBT OPPORTUNITY FUND, LLLP DATED NOVEMBER 14, 2008 LOAN AND SECURITIES PURCHASE AGREEMENT

LOAN AND SECURITIES PURCHASE AGREEMENT By and Between MDWERKS, INC., XENI FINANCIAL SERVICES, CORP. and DEBT OPPORTUNITY FUND, LLLP DATED NOVEMBER 14, 2008 LOAN AND SECURITIES PURCHASE AGREEMENT This LOAN AND SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated this 14th day of November, 2008, is made by and between MDWERKS, INC., a Delaware corporation (“MDwerks” or the “Company”), XENI FINANCI

November 20, 2008 EX-4.4

REGISTRATION RIGHTS AGREEMENT

EX-4.4 5 v133049ex4-4.htm REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement is made and entered into as of November 14, 2008 (as amended, modified or supplemented from time to time, this “Agreement”) by and between MDwerks, Inc., a Delaware corporation (the “Company”), and each securityholder identified on the signature pages hereto (each, including its successors and assigns, a “Ho

November 20, 2008 EX-10.5

SECURITY AGREEMENT

SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Security Agreement”) is made as of November 14, 2008, by and between MDWERKS, INC.

November 20, 2008 8-K

Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 14, 2008 MDWERKS, INC.

November 20, 2008 EX-10.6

SECURITY AGREEMENT

SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Security Agreement”) is made as of November 14, 2008, by and between XENI FINANCIAL SERVICES, CORP.

November 20, 2008 EX-10.10

GUARANTOR SECURITY AGREEMENT

EX-10.10 15 v133049ex10-10.htm GUARANTOR SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Security Agreement”) is made as of November 14, 2008, by and between PATIENT PAYMENT SOLUTIONS, INC., a Florida corporation (“Debtor”), and DEBT OPPORTUNITY FUND, LLLP, a limited liability limited partnership organized under the laws of the State of Florida (the “Lender”). RECITALS A. Guarantor is either a d

November 20, 2008 EX-10.1

GUARANTY AGREEMENT

GUARANTY AGREEMENT THIS GUARANTY AGREEMENT (this “Guaranty”) is made as of November 14, 2008, by and between XENI MEDICAL BILLING, CORP.

November 20, 2008 EX-10.7

GUARANTOR SECURITY AGREEMENT

EX-10.7 12 v133049ex10-7.htm GUARANTOR SECURITY AGREEMENT THIS SECURITY AGREEMENT (this “Security Agreement”) is made as of November 14, 2008, by and between MDWERKS GLOBAL HOLDINGS, INC., a Florida corporation (“Debtor”), and DEBT OPPORTUNITY FUND, LLLP, a limited liability limited partnership organized under the laws of the State of Florida (the “Lender”). RECITALS A. Guarantor is either a direc

November 12, 2008 EX-99.2

CONSENT AND WAIVER

EX-99.2 7 v131675ex99-2.htm Exhibit 99.2 CONSENT AND WAIVER This CONSENT AND WAIVER (this “Consent and Waiver”) is dated as of November 6, 2008, by and between MDWERKS, INC., a Delaware corporation (the “Company”), and GOTTBETTER CAPITAL MASTER, LTD. (in liquidation) (the “Consenting Holder”), a Cayman Islands company. WITNESSETH WHEREAS, the Consenting Holder is the sole holder of (i) a warrant,

November 12, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 9 PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This p

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 9 TO PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This prospectus supplement includes the attached Current Report on Form 10-Q

November 12, 2008 EX-99.3

CONSENT AND WAIVER

Exhibit 99.3 CONSENT AND WAIVER This CONSENT AND WAIVER (this ?Consent and Waiver?) is dated as of November 6, 2008, by and between MDWERKS, INC., a Delaware corporation (the ?Company?), and VICIS CAPITAL MASTER FUND (the ?Consenting Holder?), a series of the Vicis Capital Master Trust, a trust formed under the laws of the Cayman Islands. WITNESSETH WHEREAS, the Consenting Holder is the sole holde

November 12, 2008 EX-99.1

AMENDMENT NO. 2 MDWERKS, INC., FIRST AMENDED AND RESTATED SENIOR SECURED CONVERTIBLE NOTE

Exhibit 99.1 AMENDMENT NO. 2 to MDWERKS, INC., FIRST AMENDED AND RESTATED SENIOR SECURED CONVERTIBLE NOTE This AMENDMENT NO. 2 to the MDwerks, Inc., First Amended and Restated Senior Secured Convertible Note, dated October 19, 2006 (this “Amendment”), is dated as of November 6, 2008, by and between MDWERKS, INC., a Delaware corporation (the “Company”), and GOTTBETTER CAPITAL MASTER, LTD. (IN LIQUI

November 12, 2008 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2008 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File Number: 333-118155 MDWERKS, INC. (Exact name o

November 3, 2008 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 29, 2008

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 29, 2008 MDWERKS, INC.

November 3, 2008 EX-1.2

AMENDMENT No. 1 TO BY-LAWS MDWERKS, INC. (A DELAWARE CORPORATION)

Exhibit 1.2 AMENDMENT No. 1 TO BY-LAWS Of MDWERKS, INC. (A DELAWARE CORPORATION) The stockholders and the Board of Directors of MDwerks, Inc. (the “Corporation”) have approved the following amendments to the By-Laws of the Corporation, effective on this the 29th day of October, 2008: Section 1 of Article I of the Bylaws the Corporation is hereby amended and restated to read as follows: Section 1.

November 3, 2008 EX-1.1

Certificate of Amendment of Certificate of Incorporation

Exhibit 1.1 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF MDwerks, Inc. It is hereby certified that: 1. The name of the corporation (hereinafter called the "Corporation") is MDwerks, Inc. 2. The Certificate of Incorporation of the Corporation is hereby amended by substituting in lieu of said Article 4 the following new Article 4: 1. The total number of shares of stock which this Corp

November 3, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 8 PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This p

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 8 TO PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This prospectus supplement includes the attached Current Report on Form 8-K o

October 23, 2008 CORRESP

70 Grand Avenue River Edge, NJ 07661 tel. 201.343.3434 fax 201.343.6306 New York San Francisco Los Angeles Orange County Miami Fort Lauderdale Orlando Washington, D.C. Chicago London www.pecklaw.com Stephen P. Katz Partner Via Federal Express October

70 Grand Avenue River Edge, NJ 07661 tel. 201.343.3434 fax 201.343.6306 New York San Francisco Los Angeles Orange County Miami Fort Lauderdale Orlando Washington, D.C. Chicago London www.pecklaw.com Stephen P. Katz Partner Via Federal Express October 23, 2008 Stephen Krikorian Accounting Branch Chief United States Securities and Exchange Commission 100 F. Street, N.E. Washington, D.C. 20549 Re: MD

October 16, 2008 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 10, 2008 MDWERKS, INC. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 10, 2008 MDWERKS, INC.

October 16, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 7 PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This p

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 7 TO PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This prospectus supplement includes the attached Current Report on Form 8-K o

August 25, 2008 S-1/A

As filed with the Securities and Exchange Commission on August 25, 2008

As filed with the Securities and Exchange Commission on August 25, 2008 Registration No.

August 14, 2008 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2008 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File Number: 333-118155 MDWERKS, INC. (Exact name of reg

August 14, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 6 PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular ?Risk Factors? beginning on page 5 of the prospectus. This p

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 6 TO PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This prospectus supplement includes the attached Current Report on Form 10-Q/

August 13, 2008 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2008 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File Number: 333-118155 MDWERKS, INC. (Exact name of

July 16, 2008 S-1/A

119903As filed with the Securities and Exchange Commission on July 16, 2008

119903As filed with the Securities and Exchange Commission on July 16, 2008 Registration No.

July 15, 2008 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2008 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File Number: 333-118155 MDWERKS, INC. (Exact name of

July 15, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 5 PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This p

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 5 TO PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This prospectus supplement includes the attached Current Report on Form 10-Q/

July 8, 2008 EX-99.1

MDWERKS SIGNS A LETTER OF INTENT TO ENTER JOINT VENTURE WITH AUTOMATED HEALTHCARE SOLUTIONS TOGETHER WILL FORM NEW PHARMACEUTICAL CLAIMS COMPANY

Exhibit 99.1 CHANGING THE WAY YOU GET PAID…not the way you practice FOR IMMEDIATE RELEASE MDWERKS SIGNS A LETTER OF INTENT TO ENTER JOINT VENTURE WITH AUTOMATED HEALTHCARE SOLUTIONS TOGETHER WILL FORM NEW PHARMACEUTICAL CLAIMS COMPANY DEERFIELD BEACH, Fla. - July 8, 2008 - MDwerks, Inc. (OTCBB: MDWK), a provider of innovative web-based, electronic claims management and funding solutions for health

July 8, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 4 PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular ?Risk Factors? beginning on page 5 of the prospectus. This p

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 4 TO PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular ?Risk Factors? beginning on page 5 of the prospectus. This prospectus supplement includes the attached Current Report on Form 8-K o

July 8, 2008 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 1, 2008 MDWERKS, INC. (Exact n

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 1, 2008 MDWERKS, INC.

June 25, 2008 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 10, 2008 MDWERKS, INC.

June 25, 2008 EX-4.2

MDWERKS, INC. NON-QUALIFIED STOCK OPTION AGREEMENT

EX-4.2 2 v118091ex4-2.htm Exhibit 4.2 - Form of Non-Qualified Stock Option Agreement MDWERKS, INC. NON-QUALIFIED STOCK OPTION AGREEMENT FOR Agreement Grant of Option. MDwerks, Inc. (the “Company”) hereby grants, as of , 200 (“Date of Grant”), to (the “Optionee”) an option (the “Option”) to purchase up to shares of the Company’s Common Stock, par value $.001 per share (the “Shares”), at an exercise

June 25, 2008 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 20, 2008 MDWERKS, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 20, 2008 MDWERKS, INC.

June 25, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 3 PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This p

424B3 1 v118227424b3.htm Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 3 TO PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This prospectus supplement includes the attached two

June 25, 2008 EX-4.3

MDWERKS, INC. INCENTIVE STOCK OPTION AGREEMENT

EX-4.3 3 v118091ex4-3.htm Exhibit 4.3 - Form of Incentive Stock Option Agreement MDWERKS, INC. INCENTIVE STOCK OPTION AGREEMENT FOR Agreement 1. Grant of Option. MDwerks, Inc. (the “Company”) hereby grants, as of , 200 (“Date of Grant”), to (the “Optionee”) an option (the “Option”) to purchase up to shares of the Company’s Common Stock, par value $.001 per share (the “Shares”), at an exercise pric

May 23, 2008 S-1

As filed with the Securities and Exchange Commission on May 23, 2008

As filed with the Securities and Exchange Commission on May 23, 2008 Registration No.

May 15, 2008 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2008 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File Number: 333-118155 MDWERKS, INC. (Exact name of re

May 15, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 2 PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This p

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 2 TO PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This prospectus supplement includes the attached Current Report on Form 10-Q

May 1, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 1 PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This p

424B3 1 v112348424b3.htm Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 1 TO PROSPECTUS DATED APRIL 25, 2008 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2008 and in particular “Risk Factors” beginning on page 5 of the prospectus. This prospectus supplement includes the attached Cur

May 1, 2008 424B3

PROSPECTUS MDWERKS, INC. 5,547,072 Shares of Common Stock 573,800 Warrants to Purchase Shares of Common Stock 566,667 Series A Warrants to Purchase Shares of Common Stock The date of this prospectus is April 25, 2008. MDWERKS, INC. TABLE OF CONTENTS

Filed Pursuant to Rule 424(b)(3) Registration No.: 333-132296 PROSPECTUS MDWERKS, INC. 5,547,072 Shares of Common Stock 573,800 Warrants to Purchase Shares of Common Stock 566,667 Series A Warrants to Purchase Shares of Common Stock This prospectus relates to the sale by certain Selling Securityholders identified in this prospectus of up to an aggregate of 5,547,072 shares of common stock, par val

April 29, 2008 EX-10.1

EMPLOYMENT AGREEMENT (Executive Level)

EX-10.1 2 v112132ex10-1.htm EMPLOYMENT AGREEMENT (Executive Level) AGREEMENT, dated as of January 1, 2008, between MDwerks, Inc., a Delaware corporation (the "Company"), and the Executive identified on Exhibit A attached hereto (the "Executive"). WITNESSETH: WHEREAS, the Company desires to retain the services of the Executive and to that end desires to enter into a contract of employment with him,

April 29, 2008 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 24, 2008 MDWERKS, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 24, 2008 MDWERKS, INC.

April 15, 2008 POS AM

As filed with the Securities and Exchange Commission on April 15, 2008 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 4 ON FORM S-1/A TO FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT O

POS AM 1 v110689posam.htm As filed with the Securities and Exchange Commission on April 15, 2008 Registration Statement No. 333-132296 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 4 ON FORM S-1/A TO FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MDWERKS, INC. (Name of Small Business Issuer in Its Charter) Delaware 7389 33-1

April 11, 2008 10KSB/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-KSB/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-KSB/A (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE OF 1934 For the fiscal year ended December 31, 2007 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE OF 1934 For the transition period from to Commission file number 333-118155 MDWERKS, INC.

April 2, 2008 EX-10.12

AMENDMENT, CONSENT AND WAIVER

EX-10.12 95 v109472ex10-12.htm Exhibit 10.12 AMENDMENT, CONSENT AND WAIVER This AMENDMENT, CONSENT AND WAIVER (this “Amendment, Consent and Waiver”) is dated as of March 31, 2008, by and between MDWERKS, INC., a Delaware corporation (the “Company”), and GOTTBETTER CAPITAL MASTER, LTD. (IN LIQUIDATION), a Cayman Islands company (the “Consenting Holder”). WITNESSETH WHEREAS, pursuant to a Securities

April 2, 2008 EX-3.1

AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS SERIES B CONVERTIBLE PREFERRED STOCK MDWERKS, INC. PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW

EX-3.1 2 v109472ex3-1.htm Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS DESIGNATING SERIES B CONVERTIBLE PREFERRED STOCK OF MDWERKS, INC. PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW MDWERKS, INC., a corporation organized and existing under the Delaware General Corporation Law (hereinafter called the “Corporation”), in accordance with the provisions of Section 151

April 2, 2008 EX-4.3

MDWERKS, INC. SERIES I WARRANT TO PURCHASE COMMON STOCK

Exhibit 4.3 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURI

April 2, 2008 EX-4.4

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

EX-4.4 94 v109472ex4-4.htm Exhibit 4.4 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated this 31st day of March, 2008, is made by and between MDWERKS, INC., a Delaware corporation (the “Company”), and VICIS CAPITAL MASTER FUND (the “Purchaser”), a series of the Vicis Capital Master Trust, a trust formed under the law

April 2, 2008 EX-99.1

MDwerks, Inc. Raises $6.8 Million Through a Private Placement

Exhibit 99.1 FOR IMMEDIATE RELEASE MDwerks, Inc. Raises $6.8 Million Through a Private Placement DEERFIELD BEACH, Fla. – April 2, 2008 — MDwerks, Inc. (OTCBB: MDWK), a provider of innovative web-based, electronic claims management and funding solutions for healthcare professionals, announced today that it has raised net proceeds of $6.8 million through the sale of shares of preferred stock to Vici

April 2, 2008 EX-4.1

SECURITIES PURCHASE AGREEMENT By and Between MDWERKS, INC. VICIS CAPITAL MASTER FUND DATED MARCH 31, 2008 SECURITIES PURCHASE AGREEMENT

EX-4.1 3 v109472ex4-1.htm Exhibit 4.1 SECURITIES PURCHASE AGREEMENT By and Between MDWERKS, INC. and VICIS CAPITAL MASTER FUND DATED MARCH 31, 2008 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated this 31st day of March, 2008, is made by and between MDWERKS, INC., a Delaware corporation (the “Company”), and VICIS CAPITAL MASTER FUND (the “Purchaser”), a ser

April 2, 2008 EX-4.2

MDWERKS, INC. SERIES H WARRANT TO PURCHASE COMMON STOCK

EX-4.2 92 v109472ex4-2.htm Exhibit 4.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATI

April 2, 2008 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 31, 2008 MDWERKS, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 31, 2008 MDWERKS, INC.

March 27, 2008 EX-4.11

AMENDMENT No. 1 MDWERKS, INC. FIRST AMENDED AND RESTATED SENIOR SECURED CONVERTIBLE NOTE

EXHIBIT 4.11 AMENDMENT No. 1 To MDWERKS, INC. FIRST AMENDED AND RESTATED SENIOR SECURED CONVERTIBLE NOTE This AMENDMENT No. 1 to the MDwerks, Inc. First Amended and Restated Senior Secured Convertible Note, dated September 28, 2007 (this “Amendment”) is dated as of March 1, 2008, by and between MDWERKS, INC., a Delaware corporation (the “Company”), and GOTTBETTER CAPITAL MASTER, LTD. (IN LIQUIDATI

March 27, 2008 10KSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-KSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-KSB (Mark One) x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE OF 1934 For the fiscal year ended December 31, 2007 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE OF 1934 For the transition period from to Commission file number 333-118155 MDWERKS, INC.

March 27, 2008 EX-4.12

AMENDMENT No. 1 MDWERKS, INC. FIRST AMENDED AND RESTATED SENIOR SECURED CONVERTIBLE NOTE

EX-4.12 5 v108235ex4-12.htm EXHIBIT 4.12 AMENDMENT No. 1 To MDWERKS, INC. FIRST AMENDED AND RESTATED SENIOR SECURED CONVERTIBLE NOTE This AMENDMENT No. 1 to the MDwerks, Inc. First Amended and Restated Senior Secured Convertible Note, dated September 28, 2007 (this “Amendment”) is dated as of March 1, 2008, by and between MDWERKS, INC., a Delaware corporation (the “Company”), and GOTTBETTER CAPITA

March 12, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 10 PROSPECTUS DATED APRIL 25, 2007 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2007 and in particular “Risk Factors” beginning on page 7 of the prospectus. This

424B3 1 v106673424b3.htm Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 10 TO PROSPECTUS DATED APRIL 25, 2007 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2007 and in particular “Risk Factors” beginning on page 7 of the prospectus. This prospectus supplement includes the attached Cu

March 12, 2008 EX-10.0

EX-10.0

March 12, 2008 8-K

Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 10, 2008.

March 12, 2008 EX-99.1

MDWERKS ENTERS INTO CLAIMS PURCHASE AGREEMENT WITH CALIFORNIA BASED PHARMACEUTICAL COMPANY

CHANGING THE WAY YOU GET PAID…not the way you practice FOR IMMEDIATE RELEASE MDWERKS ENTERS INTO CLAIMS PURCHASE AGREEMENT WITH CALIFORNIA BASED PHARMACEUTICAL COMPANY DEERFIELD BEACH, Fla.

January 23, 2008 EX-4.3

MDWERKS, INC. SERIES G WARRANT TO PURCHASE COMMON STOCK

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

January 23, 2008 EX-3.1

AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS SERIES B CONVERTIBLE PREFERRED STOCK MDWERKS, INC. PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW

EX-3.1 2 v100343ex3-1.htm AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS DESIGNATING SERIES B CONVERTIBLE PREFERRED STOCK OF MDWERKS, INC. PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW MDWERKS, INC., a corporation organized and existing under the Delaware General Corporation Law (hereinafter called the “Corporation”), in accordance with the provisions of Section 151 thereof, DO

January 23, 2008 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 18, 2008 MDWERKS, INC. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 18, 2008 MDWERKS, INC.

January 23, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 9 PROSPECTUS DATED APRIL 25, 2007 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2007 and in particular “Risk Factors” beginning on page 7 of the prospectus. This p

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 9 TO PROSPECTUS DATED APRIL 25, 2007 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2007 and in particular “Risk Factors” beginning on page 7 of the prospectus. This prospectus supplement includes the attached Current Report on Form 8-K o

January 23, 2008 EX-4.1

SECURITIES PURCHASE AGREEMENT By and Between MDWERKS, INC. VICIS CAPITAL MASTER FUND DATED JANUARY 18, 2008 SECURITIES PURCHASE AGREEMENT

SECURITIES PURCHASE AGREEMENT By and Between MDWERKS, INC. and VICIS CAPITAL MASTER FUND DATED JANUARY 18, 2008 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated this 18th day of January, 2008, is made by and between MDWERKS, INC., a Delaware corporation (the “Company”), and VICIS CAPITAL MASTER FUND (the “Purchaser”), a series of the Vicis Capital Master Tr

January 23, 2008 EX-4.2

MDWERKS, INC. SERIES F WARRANT TO PURCHASE COMMON STOCK

EX-4.2 51 v100343ex4-2.htm NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT

January 23, 2008 EX-4.5

FIRST AMENDMENT TO REGISTRATION RIGHTS AGREEMENT

EX-4.5 53 v100343ex4-5.htm FIRST AMENDMENT TO REGISTRATION RIGHTS AGREEMENT This First Amendment to Registration Rights Agreement (this “Amendment”), dated January 18, 2008, amends that certain Registration Rights Agreement, dated September 28, 2007 (the “Rights Agreement”), by and between MDwerks, Inc., a Delaware corporation (the “Company”), and Vicis Capital Master Fund, a series of the Vicis C

January 4, 2008 424B3

PROSPECTUS SUPPLEMENT NO. 8 PROSPECTUS DATED APRIL 25, 2007 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2007 and in particular “Risk Factors” beginning on page 7 of the prospectus. This p

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 8 TO PROSPECTUS DATED APRIL 25, 2007 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2007 and in particular “Risk Factors” beginning on page 7 of the prospectus. This prospectus supplement includes the attached Current Report on Form 8-K o

January 4, 2008 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 31, 2007 MDWERKS, INC. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 31, 2007 MDWERKS, INC.

December 5, 2007 EX-4.1

MDWERKS, INC. CONVERTIBLE NOTE

EX-4.1 2 v096360ex4-1.htm MDWERKS, INC. CONVERTIBLE NOTE Issuance Date: December 3, 2007 Original Principal Amount: U.S. $575,000 FOR VALUE RECEIVED, MDwerks, Inc., a Delaware corporation (the “Company”), hereby promises to pay to Vicis Capital Master Fund or its registered assigns (“Holder”) the amount set out above as the Original Principal Amount (as may be reduced pursuant to the terms hereof

December 5, 2007 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 3, 2007 MDWERKS, INC.

December 5, 2007 424B3

PROSPECTUS SUPPLEMENT NO. 7 PROSPECTUS DATED APRIL 25, 2007 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2007 and in particular ?Risk Factors? beginning on page 7 of the prospectus. This p

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 7 TO PROSPECTUS DATED APRIL 25, 2007 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2007 and in particular ?Risk Factors? beginning on page 7 of the prospectus. This prospectus supplement includes the attached Current Report on Form 8-K o

November 14, 2007 424B3

PROSPECTUS SUPPLEMENT NO. 6/A PROSPECTUS DATED APRIL 25, 2007 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2007 and in particular “Risk Factors” beginning on page 7 of the prospectus. This

Filed pursuant to Rule 424(b)(3) Registration Statement File No. 333-132296 PROSPECTUS SUPPLEMENT NO. 6/A TO PROSPECTUS DATED APRIL 25, 2007 MDWERKS, INC. This prospectus supplement should be read in conjunction with our prospectus dated April 25, 2007 and in particular ?Risk Factors? beginning on page 7 of the prospectus. This prospectus supplement includes the attached Current Report on Form 10-

November 14, 2007 10QSB/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-QSB/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-QSB/A (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2007 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File Number: 333-118155 MDWERKS, INC. (Exact na

November 13, 2007 10QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-QSB (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2007 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission File Number: 333-118155 MDWERKS, INC. (Exact name

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista